Cancer Institute of New Jersey (CINJ), Breast Oncology

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Mutation Medicine & Life Sciences
Recurrence Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Kim Hirshfield

Kim Hirshfield

Rutgers, The State University

Person

19932018
No photo of Shicha Kumar

Shicha Kumar

Rutgers, The State University

Person

20102017
No photo of Coral Omene

Coral Omene

Rutgers, The State University

Person

19932018

Projects 2012 2018

Modifying The Risk For Developing Triple Negative Breast Cancer (Tnbc)

Omene, C.

National Institutes of Health (NIH)

9/15/12 → 5/31/18

Rutgers, The State University

Project: Research project

Triple Negative Breast Neoplasms
Breast Neoplasms
Neoplasms
Histone Deacetylase Inhibitors
Estrogen Receptors

Research Output 1992 2019

1 Citation (Scopus)

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

Rashkin, S. R., Chua, K. C., Ho, C., Mulkey, F., Jiang, C., Mushiroda, T., Kubo, M., Friedman, P. N., Rugo, H. S., McLeod, H. L., Ratain, M. J., Castillos, F., Naughton, M., Overmoyer, B., Toppmeyer, D., Witte, J. S., Owzar, K. & Kroetz, D. L., Mar 1 2019, In : Clinical pharmacology and therapeutics. 105, 3, p. 738-745 8 p.

Rutgers, The State University

Research output: Contribution to journal › Article

Pharmacogenetics
Disease-Free Survival
Area Under Curve
Genome
Breast Neoplasms

Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy

Manne, S., Smith, B., Mitarotondo, A., Frederick, S., Toppmeyer, D. & Kirstein, L., May 1 2019, In : Patient Education and Counseling. 102, 5, p. 902-908 7 p.

Rutgers, The State University

Research output: Contribution to journal › Article

Breast Neoplasms
Self Efficacy
Motivation
Neoplasms
Foster Home Care
1 Citation (Scopus)

Activated matriptase as a target to treat breast cancer with a drug conjugate

Rather, G. M., Lin, S. Y., Lin, H., Banach-Petrosky, W., Hirshfield, K., Lin, C. Y., Johnson, M. D., Szekely, Z. & Bertino, J., Jan 1 2018, In : Oncotarget. 9, 40, p. 25983-25992 10 p.

Rutgers, The State University

Research output: Contribution to journal › Article

Triple Negative Breast Neoplasms
Breast Neoplasms
Antibodies
Heterografts
Pharmaceutical Preparations

Press/Media

A Helping Hand from a Compassionate Team at Rutgers Cancer Institute of New Jersey

Deborah Toppmeyer

3/5/18

2 items of media coverage

Rutgers, The State University

Press/Media: Press / Media

Fighting disease with precision at Rutgers Cancer Institute of New Jersey

Hossein Khiabanian, Shridar Ganesan & Kim Hirshfield

2/26/18

3 items of media coverage

Rutgers, The State University

Press/Media: Press / Media

Using 'LOHGIC' to Assess Inherited Cancer Mutations

Hossein Khiabanian, Shridar Ganesan & Kim Hirshfield

1/23/18

1 item of media coverage

Rutgers, The State University

Press/Media: Press / Media